Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPaypoint Regulatory News (PAY)

Share Price Information for Paypoint (PAY)

Share Price is delayed by 15 minutes
Get Live Data
548.00    14.00 (2.62%)
Bid:
548.00
Ask:
549.50
Spread: 1.50 (0.274%)
Market Cap: £330.13m
PAY Live PriceLast checked at - London Stock Exchange

Intraday Paypoint Share Chart

Form 8.3 - PAYPOINT PLC

21 Feb 2023 12:23

RNS Number : 5996Q
Barclays PLC
21 February 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

PAYPOINT PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

20 Feb 2023

(f)

In addition to the company in 1(c) above, is the discloser making

YES:

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

APPRECIATE GROUP PLC

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1/3p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

121,075

0.18%

115,043

0.17%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

297,302

0.43%

95,202

0.14%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

418,377

0.61%

210,245

0.30%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1/3p ordinary

Purchase

93

4.8850 GBP

1/3p ordinary

Purchase

191

4.9400 GBP

1/3p ordinary

Purchase

205

4.8900 GBP

1/3p ordinary

Purchase

206

4.9150 GBP

1/3p ordinary

Purchase

322

4.8905 GBP

1/3p ordinary

Sale

103

4.9150 GBP

1/3p ordinary

Sale

190

4.8450 GBP

1/3p ordinary

Sale

262

4.8750 GBP

1/3p ordinary

Sale

420

4.8700 GBP

1/3p ordinary

Sale

667

4.8699 GBP

1/3p ordinary

Sale

826

4.9397 GBP

1/3p ordinary

Sale

1,699

4.8913 GBP

1/3p ordinary

Sale

2,587

4.8971 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1/3p ordinary

SWAP

Long

392

4.9399 GBP

1/3p ordinary

CFD

Long

420

4.8693 GBP

1/3p ordinary

CFD

Long

452

4.8620 GBP

1/3p ordinary

SWAP

Long

667

4.8699 GBP

1/3p ordinary

SWAP

Long

826

4.9397 GBP

1/3p ordinary

CFD

Long

1,699

4.8913 GBP

1/3p ordinary

SWAP

Long

2,195

4.8895 GBP

1/3p ordinary

CFD

Short

103

4.9150 GBP

1/3p ordinary

CFD

Short

322

4.8905 GBP

1/3p ordinary

SWAP

Short

565

4.9091 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

21 Feb 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETLFLFLXLLLBBL
Date   Source Headline
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amBUSTotal Voting Rights and Capital
27th May 202610:49 amBUSPayPoint plc : Director/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
7th May 20262:34 pmBUSResolution of claim by Global 365 Limited – Competition Appeal Tribunal Judgment
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:01 amBUSTotal Voting Rights and Capital
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20269:19 amBUSPayPoint plc : Director/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:55 pmBUSHolding(s) in Shares
1st Apr 20267:01 amBUSTotal Voting Rights and Capital
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20264:58 pmBUSPayPoint plc : Director/PDMR Shareholding
31st Mar 202612:39 pmBUSPayPoint plc : Director/PDMR Shareholding
31st Mar 20269:14 amBUSPayPoint plc : Director/PDMR Shareholding
30th Mar 20267:00 amBUSFY26 Update, Business Reorganisation and FY27 Outlook
26th Mar 20265:26 pmBUSDirectorate Change
25th Mar 20264:50 pmBUSPayPoint plc : Director/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:01 amBUSTotal Voting Rights and Capital
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20263:20 pmGNWPayPoint plc : Director/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.